ACTRN12619000633189已完成4 期
Detection of Testosterone Microdosing in Women
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- Female
入选标准
- •Healthy women aged between 18 and 60 years
- •Provide written, informed consent and willing to comply with all study requirements
排除标准
- •Pregnancy, breast feeding or seeking fertility within next 6 months
- •Using hormonal drugs other than oral contraception (eg estrogen replacement)
- •Athletes subject to regular urine drug testing
- •Contraindication to testosterone (breast cancer, polycythemia)
- •Major, serious or chronic medical disorders including chronic viral (HIV, hepatitis) infection that require regular prescribed medication
- •Severe or extensive skin disease that interferes with transdermal drug delivery
- •Regular medications that interfere with dermal absorption or metabolism of testosterone
- •History of androgen or other drug abuse within last year
- •History of major psychiatric disease or psychological condition that may limit understanding and compliance with study requirements in the investigator’s opinion
研究者
相似试验
终止
4 期
Detection of Testosterone Microdosing in Healthy MeACTRN12619001506189Sydney local Health District6
已完成
不适用
Administration of testosterone to women with androgen insensitivity: a study of the role of androgen replacement on psychological functioutritional, Metabolic, Endocrine: Androgen replacementNutritional, Metabolic, EndocrineISRCTN17551969Department of Health (UK)20
尚未招募
Unknown
Total testosterone level in women undergoing ovarian stimulation and its impact on Assisted Reproductive Technique cyclesCTRI/2023/11/059971I
招募中
3 期
Testosterone therapy for the treatment of nonalcoholic fatty liver diseaseNonalcoholic fatty liver diseaseACTRN12619000701123Austin Health120
进行中（未招募）
1 期
Does Testposterone improve the Pain Perception of Patients with Chronic Pain?Patient with persistent somatoform pain disorder (F45.40 or F45.41) should be included into the study.EUCTR2016-000048-32-DERWTH Aachen University/CTC-A60